Macrogenics (MGNX) Misses Q1 EPS by 20c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
TD Cowen Downgrades MacroGenics (MGNX) to Hold
May 10, 2024 5:30 AM EDTTD Cowen analyst Boris Peaker downgraded MacroGenics (NASDAQ: MGNX) from Buy to Hold.
The analyst comments "Efficacy was promising with 44% and 37% cPSA50s and 18% and 25% cORRs at 2.0mg and 2.7mg, respectively. However, safety deteriorated from the abstract which raises material questions.... More



